首页|茯苓甘草合剂治疗肺脾气虚型慢性阻塞性肺疾病合并肌肉衰减临床观察

茯苓甘草合剂治疗肺脾气虚型慢性阻塞性肺疾病合并肌肉衰减临床观察

扫码查看
目的 观察茯苓甘草合剂治疗肺脾气虚型慢性阻塞性肺疾病(COPD)合并肌肉衰减的临床疗效.方法 将100 例肺脾气虚型COPD合并肌肉衰减患者按照随机数字表法分为2 组,对照组50 例予常规西药治疗,治疗组50 例予茯苓甘草合剂联合常规西药治疗,2 组均连续治疗3 个月.比较2 组治疗前后中医证候评分变化;比较 2 组治疗前后肺功能指标第1s用力呼气容积(FEV1)、FEV1 占预计值百分比(FEV1%pred)、FEV1/用力肺活量(FEV1/FVC)变化;比较2 组治疗前后肌肉衰减指标[握力、四肢肌肉质量(RASM)、步行速度]、氧化应激因子[超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、活性氧(ROS)]、炎症因子[白细胞介素1(IL-1)、IL-8、肿瘤坏死因子α(TNF-α)]变化;比较2 组治疗前后COPD评估测试(CAT)评分、营养风险筛查2002(NRS 2002)评分、日常生活活动能力量表(ADL)评分变化;比较2 组不良反应.结果 2 组治疗后咳嗽气短、声低气怯、步履缓慢、乏力、肌肉萎缩评分均较本组治疗前降低(P<0.05),且治疗组降低更明显(P<0.05).2 组治疗后FEV1/FVC、FEV1%pred、FEV1 均较本组治疗前升高(P<0.05),且治疗组升高更明显(P<0.05).2 组治疗后握力、步行速度、RASM 均较本组治疗前升高(P<0.05),且治疗组升高更明显(P<0.05).2 组治疗后SOD、CAT水平均较本组治疗前升高(P<0.05),ROS水平较本组治疗前降低(P<0.05);治疗后治疗组SOD、CAT水平均高于对照组(P<0.05),ROS水平低于对照组(P<0.05).2 组治疗后血清IL-1、IL-8、TNF-α水平均较本组治疗前降低(P<0.05),且治疗组降低更明显(P<0.05).2 组治疗后CAT评分、NRS 2002 评分均较本组治疗前降低(P<0.05),ADL评分均较本组治疗前升高(P<0.05);治疗后治疗组CAT评分、NRS 2002 评分均低于对照组(P<0.05),ADL评分高于对照组(P<0.05).治疗组无不良反应;对照组恶心1 例,头晕2 例.结论 茯苓甘草合剂治疗肺脾气虚型COPD合并肌肉衰减,可提升患者肺功能,抑制氧化应激和炎性反应,并改善患者临床症状,延缓肌肉衰减,提高患者运动强度和生活质量,具有较高的安全性.
Clinical efficacy of Fuling Gancao Mixture for chronic obstructive pulmonary disease with muscle attenuation
Objective To investigate the clinical efficacy of Fuling Gancao Mixture for chronic obstructive pulmonary disease(COPD)with muscle attenuation.Methods One hundred COPD patients with muscle attenuation were randomly assigned into treatment group(n=50)and control group(n=50).All patients were managed by conventional Western medicine,and those in treatment group were additionally treated with Fuling Gancao Mixture.A 3-month treatment was performed,the aim was to compare traditional Chinese medicine(TCM)syndrome score,pulmonary function indexes(forced expiratory volume in one second[FEV1],FEV1 percentage of predictive value[FEV1%pred],FEV1 to forced vital capacity ratio[FEV1/FVC]),muscle attenuation indexes(holding power,relative skeletal muscle mass index[RASM],walking speed),oxidative stress factors(superoxide dismutase[SOD],catalase[CAT],reactive oxygen species[ROS]),inflammatory factors(interleukin-1[IL-1],IL-8,tumor necrosis factor-alpha[TNF-α]),COPD Assessment Test(CAT),Nutritional Risk Screening 2002(NRS 2002),Activities of Daily Living Scale(ADL),adverse reactions.Results After treatment,TCM symptom(cough and shortness of breath,low voice,slow walking,fatigue,and muscle atrophy)scores in the both groups were significantly decreased(P<0.05),which decreased notably in the treatment group compared with the control group(P<0.05).FEV1/FVC,FEV1%pred and FEV1 in the both groups were significantly increased(P<0.05),which were significantly higher in the treatment group than in the control group(P<0.05).The holding power,walking speed,RASM in the both groups were significantly increased(P<0.05),the increaseS in the treatment group were more prevalent compared with the control group(P<0.05).After treatment,the levels of SOD and CAT int the both groups significantly increased(P<0.05),but level of ROS significantly decreased(P<0.05),and the different was significant in the levels of SOD,CAT,and ROS between groups(P<0.05).The levels of IL-1,IL-8 and TNF-α in the both groups were significantly decreased(P<0.05),the decrease in the treatment group was more common than the control group(P<0.05).After treatment,the scores CAT and NRS 2002 significantly decreased in the two groups(P<0.05),but ADL scores significantly increased(P<0.05),and the treatment group was superior to the control group for the scores of CAT,NRS 2002 and ADL(all P<0.05).No adverse reaction in the treatment group was found,but there were adverse reactions in the control group,including 1 case of nausea and 2 cases of dizziness.Conclusion For COPD patients with muscle attenuation,Fuling Gancao Mixture can improve pulmonary function,inhibit oxidative stress and inflammatory reactions,improve clinical symptoms,delay muscle attenuation,improve exercise intensity and quality of life,and with high safety.

Pulmonary disease,chronic obstructiveTraditional Chinese medicine therapy

张巍巍、于海霞、刘霞、张积友

展开 >

山东青岛中西医结合医院肺病科,山东 青岛 266002

山东青岛中西医结合医院急救站,山东 青岛 266002

山东青岛中西医结合医院肾病科,山东 青岛 266002

肺疾病,阻塞性 中药疗法

山东省中医药科技项目

M-2022015

2024

河北中医
河北省医学情报研究所,河北省中医药学会

河北中医

CSTPCD
影响因子:0.951
ISSN:1002-2619
年,卷(期):2024.46(9)